Pharmacokinetics of a Single Dulaglutide Dose in Healthy Chinese Subjects and of Multiple Dulaglutide Doses in Chinese Patients With T2DM
Phase of Trial: Phase I
Latest Information Update: 16 Mar 2016
At a glance
- Drugs Dulaglutide (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Eli Lilly
- 30 Jul 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 02 Jun 2014 Planned End Date changed from 1 Aug 2014 to 1 Jun 2014 as reported by ClinicalTrials.gov record.
- 03 Dec 2013 Planned end date changed from 1 Apr 2014 to 1 Aug 2014 as reported by ClinicalTrials.gov.